According to FDA data, all "semaglutide" imported into the US designated for use in compounding since June 2023 originated from suppliers in China
Appropriate dose adjustments and clinical monitoring are recommended to ensure safety and therapeutic efficacy 25
10.1038/sj.bjp.0704327 369
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects
Combination with SGLT2 inhibitors to augment the benefits of this drug class in HFrEF with, for example, the weight-lowering effects of GLP-1 RA could offer a clinically valuable and feasible option addressing the spectrum of abnormalities associated with this HF phenotype
These comparisons highlight the dynamic nature of obesity treatment research and the potential for continued innovation in this field